Watchlist Price Alert

GreenLight Biosciences (GRNA)

NASDAQ: GRNA · Real-Time Price · USD

0.30

0.00 (0.13%)

At close: Jul 21, 2023, 8:00 PM

GreenLight Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-167.06M	-112.31M	-53.25M	-28.65M
Depreciation & Amortization	8.08M	5.77M	1.75M	688K
Stock-Based Compensation	8.84M	1.99M	659K	430K
Other Working Capital	15.02M	6.83M	2.47M	1.36M
Other Non-Cash Items	5M	828K	588K	30K
Deferred Income Tax	n/a	1.36M	7K	-5K
Change in Working Capital	8.41M	10.52M	3.64M	1.87M
Operating Cash Flow	-136.73M	-91.83M	-46.6M	-25.64M
Capital Expenditures	-26.55M	-15.15M	-10.05M	-1.9M
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	37K	109K	n/a	n/a
Investing Cash Flow	-26.51M	-15.04M	-10.05M	-1.9M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	200.85M	43.53M	125.85M	13.32M
Financial Cash Flow	200.85M	43.53M	125.85M	13.32M
Net Cash Flow	37.61M	-63.34M	69.2M	-14.22M
Free Cash Flow	-163.28M	-106.98M	-56.65M	-27.53M